<html>
<head>

<title>Neurogen Corporation Form S-8</title>
</head>

<body>
<p align="center"> As filed with the Securities and Exchange Commission on October 4, 2004 </p>
<p align="right"> Registration No. 333- </p>
<hr noshade>
<p align="center"><b> UNITED STATES <br>
</b><b>SECURITIES AND EXCHANGE COMMISSION <br>
</b><b>Washington</b><b>, </b><b> D.C.</b><b> 20549 <br>
</b>__________________ </p>
<p align="center"><b>FORM S-8</b></p>
<p align="center"> REGISTRATION STATEMENT <br>
UNDER <br>
THE SECURITIES ACT OF 1933 <br>
__________________ </p>
<p align="center"><font size="5"><b><b>NEUROGEN CORPORATION </b></font><br>
(Exact name of registrant as specified in its charter) </p>
<table width="100%" cellpadding="0" cellspacing="0">
  <tr>
    <td width="277" valign="top"><p align="center"> Delaware </p></td>
    <td width="132" valign="top"><p align="center">&nbsp; </p></td>
    <td width="229" valign="top"><p align="center"> 22-2845714 </p></td>
  </tr>
  <tr>
    <td width="277" valign="top"><p align="center"> (State or other jurisdiction <br>
      of incorporation or organization) </p>
    </td>
    <td width="132" valign="top"><p align="center">&nbsp; </p></td>
    <td width="229" valign="top"><p align="center"> (I.R.S. Employer Identification No.) </p></td>
  </tr>
  <tr>
    <td width="277" valign="top"><p align="center">&nbsp; </p></td>
    <td width="132" valign="top"><p align="center">&nbsp; </p></td>
    <td width="229" valign="top"><p align="center">&nbsp; </p></td>
  </tr>
  <tr>
    <td width="277" valign="top"><p align="center"> 35 Northeast Industrial Road <br>
      Branford, Connecticut </p>
    </td>
    <td width="132" valign="top"><p align="center">&nbsp; </p></td>
    <td width="229" valign="top"><p align="center"> <br>
      06405 </p>
    </td>
  </tr>
  <tr>
    <td width="277" valign="top"><p align="center"> (Address of Principal Executive Offices) </p></td>
    <td width="132" valign="top"><p align="center">&nbsp; </p></td>
    <td width="229" valign="top"><p align="center"> (Zip Code) </p></td>
  </tr>
</table>
<p>&nbsp; </p>
<p align="center"><b> Amended and Restated Neurogen Corporation 2001 Stock Option Plan <br>
</b>(Full title of the plan)</p>
<p align="center"> Stephen R. Davis, Esq. <br>
Executive Vice President and Chief Business Officer <br>
Neurogen Corporation <br>
35 Northeast Industrial Road <br>
Branford, Connecticut 06405 <br>
(Name and address of agent for service)</p>
<p align="center"> (203) 488-8201 <br>
(Telephone number, including area code, of agent for service) </p>
<p align="center"><i> Copies to:</i></p>
<p align="center"> Robert B. Williams, Esq. <br>
Milbank, Tweed , Hadley &amp; McCloy LLP <br>
1 Chase Manhattan Plaza <br>
New York, New York 10005 <br>
(212) 530-5000 </p>
<p align="center">&nbsp; </p>
<p align="center"> CALCULATION OF REGISTRATION FEE </p>
<table width="100%" cellpadding="0" cellspacing="0">
  <tr>
    <td width="144" valign="top"><p align="center">&nbsp; </p>
        <p align="center"> Title of Securities<br>
        to be Registered </p>
    </td>
    <td width="111" valign="top"><p align="center">&nbsp; </p>
        <p align="center"> Amount to be Registered (1) </p></td>
    <td width="127" valign="top"><p align="center"> Proposed<br>
      Maximum<br>
      Offering Price<br>
      Per Share (1)(2) </p>
    </td>
    <td width="127" valign="top"><p align="center">Proposed<br>
      Maximum<br>
      Aggregate<br>
      Offering Price<br>
      (1)(2) </p></td>
    <td width="130" valign="top"><p align="center"> <br>
      Amount of Registration Fee </p>
    </td>
  </tr>
  <tr>
    <td width="144" valign="top"><p> Common Stock, par value $.025 <br>
      per share (1) </p>
    </td>
    <td width="111" valign="top"><p align="center"> <br>
      1,500,000</p>
    </td>
    <td width="127" valign="top"><p align="center"> <br>
      $ 6.225 </p>
    </td>
    <td width="127" valign="top"><p align="center"> <br>
      $ 9,337,500 </p>
    </td>
    <td width="130" valign="top"><p align="center"> <br>
      $ 1,183.06 </p>
    </td>
  </tr>
</table>
<p>(1) This Registration Statement shall also cover any additional shares of common stock that become issuable under the Amended and Restated Neurogen Corporation 2001 Stock Option Plan, as amended, by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the receipt of consideration that results in an increase in the number of the outstanding shares of the Registrant&rsquo;s common stock. </p>
<p> (2) Estimated in accordance with Rule 457(h) under the Securities Act of 1933, as amended, solely for the purpose of calculating the registration fee, based upon the average of the high and low sales prices of the Registrant&rsquo;s common stock as reported on the Nasdaq National Market on September 27, 2004. </p>
<br>
<p align="center"><b> PART II</b></p>
<p align="center"><b> INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</b></p>
<p><b> ITEM 3. INCORPORATION OF DOCUMENTS BY REFERENCE </b></p>
<p> This Registration Statement on Form S-8 is being filed for the purpose of registering an additional 1,500,000 shares of our common stock that may be issued pursuant to our Amended and Restated Neurogen Corporation 2001 Stock Option Plan, as amended (the &ldquo;Plan&rdquo;). A total of 2,000,000 shares of our common stock issuable under the Plan have been previously registered pursuant to our Registration Statement on Form S-8 filed with the Securities and Exchange Commission on November 16, 2001 (Registration No. 333-73576). In accordance with the provisions of General Instruction E to Form S-8, the information contained therein is incorporated herein by reference. </p>
<p><b> ITEM 8. EXHIBITS</b></p>
<table cellspacing="0" cellpadding="0">
  <tr>
    <td width="115" valign="bottom"><p> Exhibit<br>
        <u>Number </u></p></td>
    <td width="582" valign="bottom"><p> <u>Description </u></p></td>
  </tr>
  <tr>
    <td valign="top">&nbsp;</td>
    <td valign="top">&nbsp;</td>
  </tr>
  <tr>
    <td width="115" valign="top"><p> 4.1 </p></td>
    <td width="582" valign="top"><p> Amended and Restated Neurogen Corporation 2001 Stock Option Plan, as amended (incorporated by reference to Appendix D of the Registrant&rsquo;s Definitive Proxy Statement on Schedule 14A (File No. 000-18311) filed on July 12, 2004 ). </p></td>
  </tr>
  <tr>
    <td valign="top">&nbsp;</td>
    <td valign="top">&nbsp;</td>
  </tr>
  <tr>
    <td width="115" valign="top"><p> 5.1 </p></td>
    <td width="582" valign="top"><p> Opinion of Milbank, Tweed , Hadley &amp; McCloy LLP, Counsel to Registrant. </p></td>
  </tr>
  <tr>
    <td valign="top">&nbsp;</td>
    <td valign="top">&nbsp;</td>
  </tr>
  <tr>
    <td width="115" valign="top"><p> 23.1 </p></td>
    <td width="582" valign="top"><p> Consent of Milbank, Tweed , Hadley &amp; McCloy LLP (contained in Exhibit 5.1). </p></td>
  </tr>
  <tr>
    <td valign="top">&nbsp;</td>
    <td valign="top">&nbsp;</td>
  </tr>
  <tr>
    <td width="115" valign="top"><p> 23.2 </p></td>
    <td width="582" valign="top"><p> Consent of PricewaterhouseCoopers LLP, Independent Registered Public Accounting Firm. </p></td>
  </tr>
  <tr>
    <td valign="top">&nbsp;</td>
    <td valign="top">&nbsp;</td>
  </tr>
  <tr>
    <td width="115" valign="top"><p> 24.1 </p></td>
    <td width="582" valign="top"><p> Powers of Attorney (included on signature page). </p></td>
  </tr>
</table>
<p>&nbsp;</p>
<p align="center"><b> SIGNATURES </b></p>
<p> Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Branford , State of Connecticut , on October 4, 2004. </p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
  <tr>
    <td width="34%">&nbsp;</td>
    <td colspan="2">NEUROGEN CORPORATION</td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td colspan="2">&nbsp;</td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td colspan="2">By: <u>/s/ STEPHEN R. DAVIS</u></td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td width="3%">&nbsp;</td>
    <td width="63%">Stephen R. Davis</td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td><p>Executive Vice President and Chief Business Officer </p></td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
  </tr>
</table>
<p> <b>&nbsp;</b></p>
<p align="center"><b> <a name="Power"></a>POWER OF ATTORNEY</b></p>
<p> KNOW ALL YE PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints William H. Koster and Stephen R. Davis, and each of them, his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof. </p>
<p> Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated:</p>
<table cellspacing="0" cellpadding="0">
  <tr>
    <td width="295" valign="top"><p> <u><b>SIGNATURE</b> </u></p></td>
    <td width="288" valign="top"><p> <u><b>TITLE</b></u> </p></td>
    <td width="127" valign="top"><p> <u><b>DATE</b></u> </p></td>
  </tr>
  <tr>
    <td width="295" valign="top"><p>&nbsp; </p></td>
    <td width="288" valign="top"><p>&nbsp; </p></td>
    <td width="127" valign="top"><p>&nbsp; </p></td>
  </tr>
  <tr>
    <td width="295" valign="top"><p> <u>/s/ FRANK C. CARLUCCI </u><br>
        Frank C. Carlucci </p></td>
    <td width="288" valign="top"><p> Chairman of the Board and<br>
        Director </p></td>
    <td width="127" valign="top"><p> October 4, 2004 </p></td>
  </tr>
  <tr>
    <td valign="top">&nbsp;</td>
    <td valign="top">&nbsp;</td>
    <td valign="top">&nbsp;</td>
  </tr>
  <tr>
    <td width="295" valign="top"><p> <u>/s/ WILLIAM H. KOSTER</u><br>
        William H. Koster<br>
        (Principal Executive Officer) </p></td>
    <td width="288" valign="top"><p> President, Chief Executive Officer<br>
        and Director </p></td>
    <td width="127" valign="top"><p> October 4, 2004 </p></td>
  </tr>
  <tr>
    <td valign="top">&nbsp;</td>
    <td valign="top">&nbsp;</td>
    <td valign="top">&nbsp;</td>
  </tr>
  <tr>
    <td width="295" valign="top"><p> <u>/s/ STEPHEN R. DAVIS</u><br>
        Stephen R. Davis<br>
        (Principal Financial and<br>
        Accounting Officer)</p>
    </td>
    <td width="288" valign="top"><p> Executive Vice President, Chief<br>
        Business Officer and Director </p></td>
    <td width="127" valign="top"><p> October 4, 2004 </p></td>
  </tr>
  <tr>
    <td valign="top">&nbsp;</td>
    <td valign="top">&nbsp;</td>
    <td valign="top">&nbsp;</td>
  </tr>
  <tr>
    <td width="295" valign="top"><p> <u>/s/ FELIX J. BAKER</u><br>
        Felix J. Baker </p></td>
    <td width="288" valign="top"><p> Director </p></td>
    <td width="127" valign="top"><p> October 4, 2004 </p></td>
  </tr>
  <tr>
    <td valign="top">&nbsp;</td>
    <td valign="top">&nbsp;</td>
    <td valign="top">&nbsp;</td>
  </tr>
  <tr>
    <td width="295" valign="top"><p> <u>/s/ JULIAN C. BAKER</u><br>
        Julian C. Baker </p></td>
    <td width="288" valign="top"><p> Director </p></td>
    <td width="127" valign="top"><p> October 4, 2004 </p></td>
  </tr>
  <tr>
    <td valign="top">&nbsp;</td>
    <td valign="top">&nbsp;</td>
    <td valign="top">&nbsp;</td>
  </tr>
  <tr>
    <td width="295" valign="top"><p> <u>/s/ ERAN BROSHY</u><br>
        Eran Broshy </p></td>
    <td width="288" valign="top"><p> Director </p></td>
    <td width="127" valign="top"><p> October 4, 2004 </p></td>
  </tr>
  <tr>
    <td valign="top">&nbsp;</td>
    <td valign="top">&nbsp;</td>
    <td valign="top">&nbsp;</td>
  </tr>
  <tr>
    <td width="295" valign="top"><p> <u>/s/ ROBERT N. BUTLER</u><br>
        Robert N. Butler </p></td>
    <td width="288" valign="top"><p> Director </p></td>
    <td width="127" valign="top"><p> October 4, 2004 </p></td>
  </tr>
  <tr>
    <td valign="top">&nbsp;</td>
    <td valign="top">&nbsp;</td>
    <td valign="top">&nbsp;</td>
  </tr>
  <tr>
    <td width="295" valign="top"><p> <u>/s/ STEWART HEN</u><br>
        Stewart Hen </p></td>
    <td width="288" valign="top"><p> Director </p></td>
    <td width="127" valign="top"><p> October 4, 2004 </p></td>
  </tr>
  <tr>
    <td valign="top">&nbsp;</td>
    <td valign="top">&nbsp;</td>
    <td valign="top">&nbsp;</td>
  </tr>
  <tr>
    <td width="295" valign="top"><p> <u>/s/ JONATHAN S. LEFF</u><br>
        Jonathan S. Leff </p></td>
    <td width="288" valign="top"><p> Director </p></td>
    <td width="127" valign="top"><p> October 4, 2004 </p></td>
  </tr>
  <tr>
    <td valign="top">&nbsp;</td>
    <td valign="top">&nbsp;</td>
    <td valign="top">&nbsp;</td>
  </tr>
  <tr>
    <td width="295" valign="top"><p> <u>/s/ MARK NOVITCH </u><br>
        Mark Novitch </p></td>
    <td width="288" valign="top"><p> Director </p></td>
    <td width="127" valign="top"><p> October 4, 2004 </p></td>
  </tr>
  <tr>
    <td valign="top">&nbsp;</td>
    <td valign="top">&nbsp;</td>
    <td valign="top">&nbsp;</td>
  </tr>
  <tr>
    <td width="295" valign="top"><p> <u>/s/ CRAIG SAXTON</u><br>
        Craig Saxton </p></td>
    <td width="288" valign="top"><p> Director </p></td>
    <td width="127" valign="top"><p> October 4, 2004 </p></td>
  </tr>
  <tr>
    <td valign="top">&nbsp;</td>
    <td valign="top">&nbsp;</td>
    <td valign="top">&nbsp;</td>
  </tr>
  <tr>
    <td width="295" valign="top"><p> <u>/s/ JOHN SIMON </u><br>
        John Simon </p></td>
    <td width="288" valign="top"><p> Director </p></td>
    <td width="127" valign="top"><p> October 4, 2004 </p></td>
  </tr>
  <tr>
    <td valign="top">&nbsp;</td>
    <td valign="top">&nbsp;</td>
    <td valign="top">&nbsp;</td>
  </tr>
  <tr>
    <td width="295" valign="top"><p> <u>/s/ SUZANNE H. WOOLSEY</u><br>
        Suzanne H. Woolsey </p></td>
    <td width="288" valign="top"><p> Director </p></td>
    <td width="127" valign="top"><p> October 4, 2004 </p></td>
  </tr>
</table>
<br>
<p align="center"><b> INDEX TO EXHIBITS</b></p>
<table cellspacing="0" cellpadding="0">
  <tr>
    <td width="73" valign="bottom"><p> Exhibit<br>
        <u>Number</u></p></td>
    <td width="624" valign="bottom"><p align="center"> <u>Description of Document </u></p></td>
  </tr>
  <tr>
    <td valign="top">&nbsp;</td>
    <td valign="top">&nbsp;</td>
  </tr>
  <tr>
    <td width="73" valign="top"><p> 4.1 </p></td>
    <td width="624" valign="top"><p> Amended and Restated Neurogen Corporation 2001 Stock Option Plan, as amended (incorporated by reference to Appendix D of the Registrant&rsquo;s Definitive Proxy Statement on Schedule 14A (File No. 000-18311) filed on July 12, 2004). </p></td>
  </tr>
  <tr>
    <td valign="top">&nbsp;</td>
    <td valign="top">&nbsp;</td>
  </tr>
  <tr>
    <td width="73" valign="top"><p> <a href="fs8100404exhibit51.htm">5.1</a> </p></td>
    <td width="624" valign="top"><p> Opinion of Milbank, Tweed , Hadley &amp; McCloy LLP, Counsel to Registrant. </p></td>
  </tr>
  <tr>
    <td valign="top">&nbsp;</td>
    <td valign="top">&nbsp;</td>
  </tr>
  <tr>
    <td width="73" valign="top"><p> <a href="fs8100404exhibit51.htm">23.1 </a></p></td>
    <td width="624" valign="top"><p> Consent of Milbank, Tweed , Hadley &amp; McCloy LLP (contained in Exhibit 5.1). </p></td>
  </tr>
  <tr>
    <td valign="top">&nbsp;</td>
    <td valign="top">&nbsp;</td>
  </tr>
  <tr>
    <td width="73" valign="top"><p> <a href="fs8100404exhibit232.htm">23.2</a> </p></td>
    <td width="624" valign="top"><p> Consent of PricewaterhouseCoopers LLP, Independent Registered Public Accounting Firm. </p></td>
  </tr>
  <tr>
    <td valign="top">&nbsp;</td>
    <td valign="top">&nbsp;</td>
  </tr>
  <tr>
    <td width="73" valign="top"><p> <a href="#Power">24.1</a> </p></td>
    <td width="624" valign="top"><p> Powers of Attorney (included on signature page). </p></td>
  </tr>
</table>
<p>&nbsp; </p>
<p>&nbsp; </p>
</body>
</html>
[{"type": "S-8", "sequence": "1", "filename": "fs8100404stock2001.htm", "secsgml_size_bytes": 17023}]
{"company-data": {"conformed-name": "NEUROGEN CORP", "cik": "0000849043", "assigned-sic": "2834", "irs-number": "222845714", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-119525", "film-number": "041063618"}, "business-address": {"street1": "35 NORTHEAST INDUSTRIAL RD", "city": "BRANFORD", "state": "CT", "zip": "06405", "phone": "2034888201"}, "mail-address": {"street1": "35 NORTHEAST INDUSTRIAL RD", "city": "BRANFORD", "state": "CT", "zip": "06405"}}
Neurogen Corporation Form S-8
As filed with the Securities and Exchange Commission on October 4, 2004
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington
,
D.C.
20549
__________________
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
__________________
NEUROGEN CORPORATION
(Exact name of registrant as specified in its charter)
Delaware
22-2845714
(State or other jurisdiction
of incorporation or organization)
(I.R.S. Employer Identification No.)
35 Northeast Industrial Road
Branford, Connecticut
06405
(Address of Principal Executive Offices)
(Zip Code)
Amended and Restated Neurogen Corporation 2001 Stock Option Plan
(Full title of the plan)
Stephen R. Davis, Esq.
Executive Vice President and Chief Business Officer
Neurogen Corporation
35 Northeast Industrial Road
Branford, Connecticut 06405
(Name and address of agent for service)
(203) 488-8201
(Telephone number, including area code, of agent for service)
Copies to:
Robert B. Williams, Esq.
Milbank, Tweed , Hadley & McCloy LLP
1 Chase Manhattan Plaza
New York, New York 10005
(212) 530-5000
CALCULATION OF REGISTRATION FEE
Title of Securities
to be Registered
Amount to be Registered (1)
Proposed
Maximum
Offering Price
Per Share (1)(2)
Proposed
Maximum
Aggregate
Offering Price
(1)(2)
Amount of Registration Fee
Common Stock, par value $.025
per share (1)
1,500,000
$ 6.225
$ 9,337,500
$ 1,183.06
(1) This Registration Statement shall also cover any additional shares of common stock that become issuable under the Amended and Restated Neurogen Corporation 2001 Stock Option Plan, as amended, by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the receipt of consideration that results in an increase in the number of the outstanding shares of the Registrant's common stock.
(2) Estimated in accordance with Rule 457(h) under the Securities Act of 1933, as amended, solely for the purpose of calculating the registration fee, based upon the average of the high and low sales prices of the Registrant's common stock as reported on the Nasdaq National Market on September 27, 2004.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
ITEM 3. INCORPORATION OF DOCUMENTS BY REFERENCE
This Registration Statement on Form S-8 is being filed for the purpose of registering an additional 1,500,000 shares of our common stock that may be issued pursuant to our Amended and Restated Neurogen Corporation 2001 Stock Option Plan, as amended (the "Plan"). A total of 2,000,000 shares of our common stock issuable under the Plan have been previously registered pursuant to our Registration Statement on Form S-8 filed with the Securities and Exchange Commission on November 16, 2001 (Registration No. 333-73576). In accordance with the provisions of General Instruction E to Form S-8, the information contained therein is incorporated herein by reference.
ITEM 8. EXHIBITS
Exhibit
Number
Description
4.1
Amended and Restated Neurogen Corporation 2001 Stock Option Plan, as amended (incorporated by reference to Appendix D of the Registrant's Definitive Proxy Statement on Schedule 14A (File No. 000-18311) filed on July 12, 2004 ).
5.1
Opinion of Milbank, Tweed , Hadley & McCloy LLP, Counsel to Registrant.
23.1
Consent of Milbank, Tweed , Hadley & McCloy LLP (contained in Exhibit 5.1).
23.2
Consent of PricewaterhouseCoopers LLP, Independent Registered Public Accounting Firm.
24.1
Powers of Attorney (included on signature page).
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Branford , State of Connecticut , on October 4, 2004.
NEUROGEN CORPORATION
By:
/s/ STEPHEN R. DAVIS
Stephen R. Davis
Executive Vice President and Chief Business Officer
POWER OF ATTORNEY
KNOW ALL YE PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints William H. Koster and Stephen R. Davis, and each of them, his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated:
SIGNATURE
TITLE
DATE
/s/ FRANK C. CARLUCCI
Frank C. Carlucci
Chairman of the Board and
Director
October 4, 2004
/s/ WILLIAM H. KOSTER
William H. Koster
(Principal Executive Officer)
President, Chief Executive Officer
and Director
October 4, 2004
/s/ STEPHEN R. DAVIS
Stephen R. Davis
(Principal Financial and
Accounting Officer)
Executive Vice President, Chief
Business Officer and Director
October 4, 2004
/s/ FELIX J. BAKER
Felix J. Baker
Director
October 4, 2004
/s/ JULIAN C. BAKER
Julian C. Baker
Director
October 4, 2004
/s/ ERAN BROSHY
Eran Broshy
Director
October 4, 2004
/s/ ROBERT N. BUTLER
Robert N. Butler
Director
October 4, 2004
/s/ STEWART HEN
Stewart Hen
Director
October 4, 2004
/s/ JONATHAN S. LEFF
Jonathan S. Leff
Director
October 4, 2004
/s/ MARK NOVITCH
Mark Novitch
Director
October 4, 2004
/s/ CRAIG SAXTON
Craig Saxton
Director
October 4, 2004
/s/ JOHN SIMON
John Simon
Director
October 4, 2004
/s/ SUZANNE H. WOOLSEY
Suzanne H. Woolsey
Director
October 4, 2004
INDEX TO EXHIBITS
Exhibit
Number
Description of Document
4.1
Amended and Restated Neurogen Corporation 2001 Stock Option Plan, as amended (incorporated by reference to Appendix D of the Registrant's Definitive Proxy Statement on Schedule 14A (File No. 000-18311) filed on July 12, 2004).
5.1
Opinion of Milbank, Tweed , Hadley & McCloy LLP, Counsel to Registrant.
23.1
Consent of Milbank, Tweed , Hadley & McCloy LLP (contained in Exhibit 5.1).
23.2
Consent of PricewaterhouseCoopers LLP, Independent Registered Public Accounting Firm.
24.1
Powers of Attorney (included on signature page).